[{"Assets_0_FY_USD":414227000.0,"CommonStockSharesOutstanding_0_FY_shares":19395000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":29220000.0,"NetIncomeLoss_1_FY_USD":27420000.0,"NetIncomeLoss_4_FY_USD":71956000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":20650000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":19255000.0,"StockholdersEquity_0_FY_USD":393679000.0,"EarningsPerShareBasic_4_FY_USD":3.74,"EarningsPerShareBasic_1_FY_USD":1.41,"EarningsPerShareDiluted_4_FY_USD":3.48,"EarningsPerShareDiluted_1_FY_USD":1.3,"RevenueFromContractWithCustomerExcludingAssessedTax_4_FY_USD":206625000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_FY_USD":67205000.0,"Ticker":"ENTA","CIK":"1177648","name":"ENANTA PHARMACEUTICALS INC","OfficialName":"Enanta Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20180930","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1492537180.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20181129"}]